Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry

English version České info

Using data from the ASIAN-HF Registry, Carolyn Lam and colleagues examine multimorbidity patterns in patients with heart failure from 11 Asian countries

Vyšlo v časopise: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002541
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002541

Souhrn

Using data from the ASIAN-HF Registry, Carolyn Lam and colleagues examine multimorbidity patterns in patients with heart failure from 11 Asian countries

Zdroje

1. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64:2281–93. doi: 10.1016/j.jacc.2014.08.036 25456761

2. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59:998–1005. doi: 10.1016/j.jacc.2011.11.040 22402071

3. van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16:103–11. doi: 10.1002/ejhf.30 24453099

4. Lam CSP, Teng T-HK, Tay WT, Anand I, Zhang S, Shimizu W, et al. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016; 3141–53. doi: 10.1093/eurheartj/ehw331 27502121

5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975. doi: 10.1002/ejhf.592 27207191

6. Shah AM. Ventricular remodeling in heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10:341–9. doi: 10.1007/s11897-013-0166-4 24097113

7. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263–71. doi: 10.1016/j.jacc.2013.02.092 23684677

8. Bayes-Genis A, Voors AA, Zannad F, Januzzi JL, Richards AM, Díez J. Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. Eur Heart J. 2017;133:226–31. doi: 10.1093/eurheartj/ehx027 28204449

9. Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KAA, Katus H, et al. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J. 2014;35:3250–7. doi: 10.1093/eurheartj/ehu312 25148837

10. Ahmad T, Pencina MJ, Schulte PJ, O’Brien E, Whellan DJ, Piña IL, et al. Clinical implications of chronic heart failure phenotypes defined by cluster analysis. J Am Coll Cardiol. 2014;64:1765–74. doi: 10.1016/j.jacc.2014.07.979 25443696

11. Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction. Circulation. 2016;134:73–90. doi: 10.1161/CIRCULATIONAHA.116.021884 27358439

12. Tromp J, Meyer S, Mentz RJ, O’Connor CM, Metra M, Dittrich HC, et al. Acute heart failure in the young: clinical characteristics and biomarker profiles. Int J Cardiol. 2016;221:1067–72. doi: 10.1016/j.ijcard.2016.06.339 27448534

13. Tromp J, Khan MAF, Klip IT, Meyer S, de Boer RA, Jaarsma T, et al. Biomarker profiles in heart failure patients with preserved and reduced ejection fraction. J Am Heart Assoc. 2017;6:e003989. doi: 10.1161/JAHA.116.003989 28360225

14. Lam CSP, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, et al. Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) registry. Eur J Heart Fail. 2013;15:928–36. doi: 10.1093/eurjhf/hft045 23568645

15. Chia YMF, Teng T-HK, Tan ESJ, Tay WT, Richards AM, Chin CWL, et al. Disparity between indications for and utilization of implantable cardioverter defibrillators in Asian patients with heart failure. Circ Cardiovasc Qual Outcomes. 2017;10:e003651. doi: 10.1161/CIRCOUTCOMES.116.003651 29150533

16. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245–55. 10758967

17. Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail. 2013;6:1139–46. doi: 10.1161/CIRCHEARTFAILURE.113.000359 24130003

18. Comín-Colet J, Garin O, Lupón J, Manito N, Crespo-Leiro MG, Gómez-Bueno M, et al. Validation of the Spanish version of the Kansas City Cardiomyopathy Questionnaire. Rev Esp Cardiol. 2011;64:51–8. doi: 10.1016/j.recesp.2010.10.003 21194819

19. Patidar AB, Andrews GR, Seth S. Prevalence of obstructive sleep apnea, associated risk factors, and quality of life among Indian congestive heart failure patients: a cross-sectional survey. J Cardiovasc Nurs. 2011;26:452–9. doi: 10.1097/JCN.0b013e31820a048e 21372733

20. Chen H-M, Clark AP, Tsai L-M, Lin C-C. Self-reported health-related quality of life and sleep disturbances in Taiwanese people with heart failure. J Cardiovasc Nurs. 2010;25:503–13. doi: 10.1097/JCN.0b013e3181e15c37 20938252

21. Luo N, Teng T-HK, Tay WT, Anand IS, Kraus WE, Liew HB, et al. Multi-national and multi-ethnic variations in health-related quality of life in patients with chronic heart failure. Am Heart J. 2017;191:75–81. doi: 10.1016/j.ahj.2017.06.016 28888273

22. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14. doi: 10.1016/j.echo.2014.10.003 25559473

23. Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Softw. 2011;42:1–29. doi: 10.18637/jss.v042.i10

24. Forster MMR. Key concepts in model selection: performance and generalizability. J Math Psychol. 2000;44:205–31. doi: 10.1006/jmps.1999.1284 10733865

25. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461–4. doi: 10.1214/aos/1176344136

26. Shah AM, Solomon SD. Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J. 2012;33:1716–7. doi: 10.1093/eurheartj/ehs124 22730487

27. Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol. PLoS ONE. 2012; 7(11): e48184. doi: 10.1371/journal.pone.0048184 23144856

28. Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, et al. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015;17:925–35. doi: 10.1002/ejhf.327 26250359

29. Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015;131:269–79. doi: 10.1161/CIRCULATIONAHA.114.010637 25398313

30. Francis GS, Cogswell R, Thenappan T. The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success? J Am Coll Cardiol. 2014;64:1775–6. doi: 10.1016/j.jacc.2014.07.978 25443697

31. Lee CS, Chien C V, Bidwell JT, Gelow JM, Denfeld QE, Masterson Creber R, et al. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord. 2014;14:73. doi: 10.1186/1471-2261-14-73 24898986

32. World Health Organization. Global Health Observatory (GHO) data: overweight and obesity. Geneva: World Health Organization; 2017 [cited 2018 Jan 31]. Available from: http://www.who.int/gho/ncd/risk_factors/overweight/en/.

33. Omran AR. The epidemiologic transition theory revisited thirty years later. World Health Stat Q. 1998;51:99–119.

34. Omran AR. The epidemiologic transition theory. A preliminary update. J Trop Pediatr. 1983;29:305–16. 6672237

35. Sellayah D, Cagampang FR, Cox RD. On the evolutionary origins of obesity: a new hypothesis. Endocrinology. 2014;155:1573–88. doi: 10.1210/en.2013-2103 24605831

36. Bank IEM, Gijsberts CM, Teng T-HK, Benson L, Sim D, Yeo PSD, et al. Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure. JACC Heart Fail. 2017;5:14–24. doi: 10.1016/j.jchf.2016.09.015 28447583

37. Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455–69. doi: 10.1093/eurheartj/eht386 24164864

38. Jorde LB, Wooding SP. Genetic variation, classification and “race.” Nat Genet. 2004;36:S28–33. doi: 10.1038/ng1435 15508000

39. Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, et al. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail. 2012;5:710–9. doi: 10.1161/CIRCHEARTFAILURE.112.968594 23076838

40. Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, et al. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J. 2014;35:3442–51. doi: 10.1093/eurheartj/ehu254 24980489

41. Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136:6–19. doi: 10.1161/CIRCULATIONAHA.116.026807 28381470

42. Lam CSP, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation. 2007;115:1982–90. doi: 10.1161/CIRCULATIONAHA.106.659763 17404159

43. Selvaraj S, Aguilar FG, Martinez EE, Beussink L, Kim K-YA, Peng J, et al. Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN Study. J Am Heart Assoc. 2014;3:e000631. doi: 10.1161/JAHA.113.000631 24780206

44. Noordali H, Loudon BL, Frenneaux MP, Madhani M. Cardiac metabolism—a promising therapeutic target for heart failure. Pharmacol Ther. 2017;182:95–114. doi: 10.1016/j.pharmthera.2017.08.001 28821397

45. Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al. Effect of Caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction. JAMA. 2016;315:36. doi: 10.1001/jama.2015.17346 26746456

46. Choi D-J, Han S, Jeon E-S, Cho M-C, Kim J-J, Yoo B-S, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure Registry. Korean Circ J. 2011;41:363–71. doi: 10.4070/kcj.2011.41.7.363 21860637

47. Harikrishnan S, Sanjay G, Anees T, Viswanathan S, Vijayaraghavan G, Bahuleyan CG, et al. Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry. Eur J Heart Fail. 2015;17:794–800. doi: 10.1002/ejhf.283 26011246

48. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H, CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan—first report from the CHART-2 study. Circ J. 2011;75:823–33. 21436596

49. Lee R, Chan S-P, Chan Y-H, Wong J, Lau D, Ng K. Impact of race on morbidity and mortality in patients with congestive heart failure: a study of the multiracial population in Singapore. Int J Cardiol. 2009;134:422–5. doi: 10.1016/j.ijcard.2007.12.107 18372060

50. Leong KTG, Goh PP, Chang BC, Lingamanaicker J. Heart failure cohort in Singapore with defined criteria: clinical characteristics and prognosis in a multi-ethnic hospital-based cohort in Singapore. Singapore Med J. 2007;48:408–14. 17453098